Related MeSH Hierarchy (4)
Diseases [C] » Immune System Diseases [C20] » Hypersensitivity » Hypersensitivity, Immediate » Respiratory Hypersensitivity » Rhinitis, Allergic
Diseases [C] » Respiratory Tract Diseases [C08] » Nose Diseases » Rhinitis » Rhinitis, Allergic
Diseases [C] » Respiratory Tract Diseases [C08] » Respiratory Hypersensitivity » Rhinitis, Allergic
Diseases [C] » Otorhinolaryngologic Diseases [C09] » Nose Diseases » Rhinitis » Rhinitis, Allergic
Description
An inflammation of the NASAL MUCOSA triggered by ALLERGENS. MeSH
Hierarchy View
Subtype Terms (2)
Rhinitis, Allergic, Perennial
58 drugs (33 approved, 25 experimental)
Rhinitis, Allergic, Seasonal
122 drugs (59 approved, 63 experimental)
Approved Indicated Drugs (19)
Phase 4 Indicated Drugs (32)
Phase 3 Indicated Drugs (26)
Phase 2 Indicated Drugs (35)
Phase 1 Indicated Drugs (26)
Other Experimental Indicated Drugs (25)
Organization Involved with Phase 4 Indications (69)
AAADRS Clinical Research Center
Biogenics Research Chamber, LLC
California Allergy and Asthma Medical Group, Inc.
Handok Pharmaceuticals Co., Ltd.
Institut für Atemwegsforschung GmbH
Instituto di Biomedicina ed immunologia molecolare
Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
Istituto per la Ricerca e l'Innovazione Biomedica
Iuliu Hatieganu University of Medicine and Pharmacy
National Institute of Child Health Karachi.
National Research Council of Thailand
New York City Health and Hospitals Corporation
Scottish Centre for Respiratory Reseach
Organization Involved with Phase 3 Indications (97)
Ahn-Gook Pharmaceuticals Co.,Ltd
Allergisa Pesquisa Dermato-Cosmetica LTDA
Allergists and Immunologists, Fort Lauderdale
Clinical Research International Limited
Clínica Virgen del Rosario, Algeciras
Committee on Chinese Medicine and Pharmacy
Fondazione Toscana Gabriele Monasterio
Government Pharmaceutical Organization
Guangdong Provincial Hospital of Traditional Chinese Medicine
LAL Clinical Reseach e Development Ltda
National Autonomous University of Mexico
Novum Pharmaceutical Research Services
Organization Involved with Phase 2 Indications (83)
Aeroallergy Research Laboratories
Allergy and Asthma Medical Group and Research Center, San Diego
Allergy & Asthma Consultant, NJ
American College of Allergy, Asthma and Immunology
Central Texas Allergy and Asthma
China Academy of Chinese Medical Sciences
Chinese Academy of Medical Sciences
Dynavax Technologies Corporation
Gulf Coast Research Associates, Inc
Hammersmith Medicines Research
Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust
National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health (NIH)
National University of Singapore
Organization Involved with Phase 1 Indications (31)
Organization Involved with Other Experimental Indications (30)
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Cosmetique Active International
Federal University of Uberlandia
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
